RS Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | $98.4M | Sell |
1,322,074
-140,736
| -10% | -$10.5M | 1.01% | 13 |
|
|
2016
Q1 | $97.7M | Sell |
1,462,810
-284,027
| -16% | -$19M | 0.97% | 16 |
|
|
2015
Q4 | $118M | Sell |
1,746,837
-464,069
| -21% | -$31.4M | 1.06% | 16 |
|
|
2015
Q3 | $118M | Buy |
2,210,906
+635,221
| +40% | +$33.9M | 1.05% | 11 |
|
|
2015
Q2 | $99.2M | Sell |
1,575,685
-327,878
| -17% | -$20.6M | 0.85% | 20 |
|
|
2015
Q1 | $91.6M | Sell |
1,903,563
-389,769
| -17% | -$18.7M | 0.82% | 27 |
|
|
2014
Q4 | $76.1M | Sell |
2,293,332
-100,965
| -4% | -$3.35M | 0.68% | 35 |
|
|
2014
Q3 | $70.2M | Buy |
2,394,297
+162,624
| +7% | +$4.77M | 0.65% | 45 |
|
|
2014
Q2 | $86.7M | Buy |
2,231,673
+271,994
| +14% | +$10.6M | 0.73% | 30 |
|
|
2014
Q1 | $82.2M | Sell |
1,959,679
-148,423
| -7% | -$6.23M | 0.48% | 52 |
|
|
2013
Q4 | $69.2M | Buy |
2,108,102
+1,160,136
| +122% | +$38.1M | 0.42% | 65 |
|
|
2013
Q3 | $25.6M | Buy |
+947,966
| New | +$25.6M | 0.17% | 158 |
|